ill in Medical Technology
Navigation Links
ill in Medical Technology
Response to March 24 article in the New England Journal of Medicine
ALEXANDRIA, Va. and JACKSONVILLE, Fla., March 24 /PRNewswire-USNewswire/ -- A study published online today in the New England Journal of Medicine suggests that intensive blood glucose (sugar) control for critical ...
EXCLAIM is the First International Study to Show That Extended Thromboprophylaxis Reduces VTE Risk in Acutely-ill Medical Patients With a Statistically Significant 44% PARIS, July 8, 2007 /PRNewswire-FirstCall/ --Sanofi-aventis announced today the results of the EXCLAIM (EXtended CLinical prophy...
...ious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer Inc to develop and commercialize Dimebon for the...
...ients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants ann...
...andomized controlled clinical trials in critically ill patients in ICUs with diabetes or elevated blood g...hieving them in both critically and non-critically ill patients. Recognizing the importance of glyce...ed glucose targets of 140-180 mg/dL for critically ill patients in ICU settings. "We are witnessing ...
...l advance through the clearly defined regulatory process with the FDA to seek licensure of PROVENGE to fulfill our mission of serving these critically ill patients who currently have few appealing treatment options." "We are incredibly grateful to our clinical investigators, the scientific communit...
...tients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants ann...
...ients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants ann...
...ients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants ann...
...drugs, our scientific colleagues who lend their expertise, and advocates around the globe who work to ensure that the voices of those who are poor and ill are heard. While the path remains difficult and uncharted, we have good reason to carry on with hope. A comprehensive HIV prevention strategy that inc...
...ious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation entered into a global agreement with Pfizer Inc to develop and commercialize Dimebon for ...
...Heart EXCOR Pediatric is a mechanical cardiac support system for critically ill pediatric patients suffering from severe heart failure. Unlike standard hea...ents for internal and external use to stabilise cardiac activity in acutely ill patients. Its products are market leaders in their respective segments in G...
...iving a heart transplant. After 19 months of follow up, the other eight were alive with new hearts. Children who need heart transplants and are very ill can be placed on external circulatory support machines, but their long-term use is associated with significant risks. Patients also must be immobilize...
...one, World Vision has trained more than 59,000 home visitors who provide care for over 900,000 orphans and vulnerable children, as well as chronically ill adults. In 2008, World Vision aims to assemble at least 125,000 kits. Caregiver Kits provide basic supplies for as many as three months. When purcha...
...ious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzh...
...ious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzh...
...d cancers for which there are limited treatment options. Medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of dimebon(TM) in ...
...ntrol groups were 23 percent (three of 13) and 14 percent (one of seven), respectively. "Our goal is to develop life-saving treatment for critically ill people suffering from acute, sustained blood loss, such as in a car accident or on the battlefield," said senior author Roth. "These findings have obv...
...ical course, with rapid deterioration and high fatality. Primary viral pneumonia and multi-organ failure have been common among people who have become ill with avian influenza. About Baxter Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with t...
...d cancers for which there are limited treatment options. Medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon(TM) in ...
...d cancers for which there are limited treatment options. Medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon(TM) in ...
...be removed from the mouth and is environmentally as damaging as a cigarette. This gives off no smoke and is unaffected by smoking bans. This is not an ill tasting lozenge. This is in fact the new way for adult tobacco users to gain satisfaction in a simple straightforward manner. Easier to use than SNUS,...
...d cancers for which there are limited treatment options. Medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon(TM) in ...
Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill
DENVER, July 28 /PRNewswire/ -- More research shows that polyunsaturated fatty acids (PUFAs), mainly the omega-3s found in fish, benefit maternal and infant health, immune function and total parenteral nutrition (TPN). The June 2008 Fats of Life and PUFA Newsletter electronic publications summ...EXCLAIM is the First International Study to Show That Extended Thromboprophylaxis Reduces VTE Risk in Acutely-ill Medical Patients With a Statistically Significant 44% PARIS, July 8, 2007 /PRNewswire-FirstCall/ --Sanofi-aventis announced today the results of the EXCLAIM (EXtended CLinical prophy...
Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
...s finest resources for diagnosis, treatment and research. Founded in 1901, Children's Hospital Los Angeles has been treating the most seriously ill and injured children in Los Angeles for more than a century, and it is acknowledged throughout the United States and around the world for its leadersh......ious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer Inc to develop and commercialize Dimebon for the...
...ients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants ann...
...andomized controlled clinical trials in critically ill patients in ICUs with diabetes or elevated blood g...hieving them in both critically and non-critically ill patients. Recognizing the importance of glyce...ed glucose targets of 140-180 mg/dL for critically ill patients in ICU settings. "We are witnessing ...
...l advance through the clearly defined regulatory process with the FDA to seek licensure of PROVENGE to fulfill our mission of serving these critically ill patients who currently have few appealing treatment options." "We are incredibly grateful to our clinical investigators, the scientific communit...
Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
...f leading cancer centers in the United States. The prestige of these centers is a validation of the need for a viable treatment option for these very ill patients. Continuing to expand this trial assists in the acceleration of enrollment, increases the awareness of the Delcath PHP System(TM) among phys......tients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants ann...
...ients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants ann...
...ients diagnosed annually. In the setting of an aging global population, heart failure is the number one reason for hospitalization. The most severely ill patients need heart transplants in order to recover. More than 8,000 people worldwide are on the list of eligible candidates for heart transplants ann...
Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds
...evention and control of infections caused by these multidrug resistant bacteria. A. baumannii is a severe, difficult-to-treat infection in seriously ill hospitalized patients. C. difficile is resistant to numerous drugs and causes serious infection among patients already on antibiotics. The......drugs, our scientific colleagues who lend their expertise, and advocates around the globe who work to ensure that the voices of those who are poor and ill are heard. While the path remains difficult and uncharted, we have good reason to carry on with hope. A comprehensive HIV prevention strategy that inc...
...ious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation entered into a global agreement with Pfizer Inc to develop and commercialize Dimebon for ...
Portable CT Increases Chance of Stroke Survival and Recovery
...ere access to CT scanning may be limited. When a CT scanner is available, it is not always in proximity to the ER, making transportation of critically ill patients to the radiology department both difficult and time-consuming. "A portable eight-slice CT can be easily added and used to accurately...New Cancer Treatment Shrinks Pancreatic Tumor
... life he can truly enjoy." The patient's daughter discussed her father's treatment, saying "He began the NeoPlas treatment after he became too ill to complete his final course of radiation following chemotherapy." She added, "Since then, he has been able to resume work two to three hours a day, g...Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
...utics company focused on the development and commercialization of innovative pharmaceuticals and drug-device combinations for hospitalized, critically ill patients. The company's lead product, INOmax(R) (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory ...Inhaled Nitric Oxide Data Presented at European Academy of Pediatrics Meeting
... on the development and commercialization of innovative pharmaceuticals, biologic messengers and drug-device combinations for hospitalized, critically ill patients. The company's lead product, INOmax(R) (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory ......Heart EXCOR Pediatric is a mechanical cardiac support system for critically ill pediatric patients suffering from severe heart failure. Unlike standard hea...ents for internal and external use to stabilise cardiac activity in acutely ill patients. Its products are market leaders in their respective segments in G...
...iving a heart transplant. After 19 months of follow up, the other eight were alive with new hearts. Children who need heart transplants and are very ill can be placed on external circulatory support machines, but their long-term use is associated with significant risks. Patients also must be immobilize...
Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
...he effectiveness of crofelemer from a study for CRO-ID in treating severely ill cholera patients in conjunction with an antibiotic and rehydration therapy.... a single oral dose of azithromycin and rehydration therapy. These severely ill cholera patients, even when receiving the antibiotic azithromycin and rehyd......one, World Vision has trained more than 59,000 home visitors who provide care for over 900,000 orphans and vulnerable children, as well as chronically ill adults. In 2008, World Vision aims to assemble at least 125,000 kits. Caregiver Kits provide basic supplies for as many as three months. When purcha...
Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test
...linical research in Europe. The main opponents are dangerous, antibiotic-resistant bacteria (MRSA), with which more and more patients worldwide fall ill in clinics and nursing homes. Classical sanitary measures are often insufficient to prevent a further spreading. According to the clinic and the invol...Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
... taking ZIAGEN and call your doctor right away: 1. Fever 2. Rash 3. Nausea, vomiting, diarrhea, or abdominal (stomach area) pain 4. Generally ill feeling, extreme tiredness, or achiness 5. Shortness of breath, cough, or sore throat Carefully read the Warning Card that your pharmacist gives yo......ious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzh...
...ious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzh...
Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease
...erious diseases for which there are limited treatment options. Medivation aims to improve the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon(TM) in ......d cancers for which there are limited treatment options. Medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of dimebon(TM) in ...
...ntrol groups were 23 percent (three of 13) and 14 percent (one of seven), respectively. "Our goal is to develop life-saving treatment for critically ill people suffering from acute, sustained blood loss, such as in a car accident or on the battlefield," said senior author Roth. "These findings have obv...
Genzyme and Isis Complete Licensing of Mipomersen
...e $75 million in milestone payments early. "Mipomersen is an innovative treatment that has the potential to change the standard of care for severely ill patients whose needs cannot be addressed by current cholesterol-lowering therapies," said Henri A. Termeer, Genzyme's chairman and chief executive off......ical course, with rapid deterioration and high fatality. Primary viral pneumonia and multi-organ failure have been common among people who have become ill with avian influenza. About Baxter Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with t...
...d cancers for which there are limited treatment options. Medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon(TM) in ...
...d cancers for which there are limited treatment options. Medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon(TM) in ...
Study Findings Show Infection Control Intervention Helps Keep Kids in School
...trointestinal illnesses are extremely common for school-age children, and children can be at risk for these infections because of frequent exposure to ill peers and poor hand hygiene.(1) In fact, the bacteria and viruses that cause these gastrointestinal infections can be easily passed from one person to...Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
...ow transplantations in blood cancer patients. The company has three products in clinical development that offer novel treatment options for terminally ill blood cancer patients and address high-unmet medical needs. Kiadis Pharma is headquartered in Amsterdam, The Netherlands with facilities in Groningen,......be removed from the mouth and is environmentally as damaging as a cigarette. This gives off no smoke and is unaffected by smoking bans. This is not an ill tasting lozenge. This is in fact the new way for adult tobacco users to gain satisfaction in a simple straightforward manner. Easier to use than SNUS,...
Amikacin Inhale Shows Promising Results in Phase II Study
...larly high risk of developing pneumonia. Most of them are already seriously ill because of severe underlying diseases," said Professor Michael Niederman, C...istance. This allows for a unique full course of drug therapy in critically ill patients with Gram-negative pneumonia. 'Gram-negative pneumonia' refers to ...Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
...n goal of providing therapeutic options for currently unmet critical care needs. It is Ikaria's mission to develop novel treatments for the critically ill in the in hospital and ICU setting -- an area of medicine that is highly underserved, yet represents a multi-billion-dollar market." Hydrogen sulfid......d cancers for which there are limited treatment options. Medivation aims to revolutionize the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon(TM) in ...
Other TagsOther Contentsquadriplegiaquitquitquitquitrabbitrabbitrabbitrabbitrabbitrabbitrabbitrabbitrabiesrabiesrabiesracingracingracingracingindicesindicesdislocationheadheadheadheadheadheadheadheadheadhead
FampridineTNFeradeProdrugDTSResectableFOLFOX4oxaliplatinLabetuzumabAxitinibRatiometricHuMaxUFTCilengitideduloxetine
(Date:12/3/2009)...cies can be likened to emptying a museum of its co...edicines into the trash, or replacing every local ...ne of species and their habitats may not just make...y also put you at greater risk for catching some n...rsity loss,"driven by the replacement of local spe...
(Date:12/3/2009)...elieve that staph infections are caused by many ba...s. The signaling process is called quorum sensing ... process. , But the Jeff Brinker research group ...infection, when bacteria switch from a harmless to... this individual process can be stopped by the app...
(Date:12/3/2009)...e design of the upcoming forest deal at Copenhagen...g to a scientist at the University of Leeds. , ...hat at least 50% of the carbon credit payments to ...missions from Deforestation and Degredation), shou...property rights assured. , "There is the potenti...
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2MapleWorks 26apos 3B Video Application Development Technology Allows for High Level of Collaboration Cooperation 58626 1MapleWorks 26apos 3B Video Application Development Technology Allows for High Level of Collaboration Cooperation 58626 2MapleWorks 26apos 3B Video Application Development Technology Allows for High Level of Collaboration Cooperation 58626 3Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 1Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 2ZyDoc Solves Medical Data Transfer Issues with ZyDoc Messenger and Managed File Transfer 28MFT 29 Workflow Software 58622 1ZyDoc Solves Medical Data Transfer Issues with ZyDoc Messenger and Managed File Transfer 28MFT 29 Workflow Software 58622 2ZyDoc Solves Medical Data Transfer Issues with ZyDoc Messenger and Managed File Transfer 28MFT 29 Workflow Software 58622 3ZyDoc Solves Medical Data Transfer Issues with ZyDoc Messenger and Managed File Transfer 28MFT 29 Workflow Software 58622 4(Date:12/4/2009)...4 In response to the U....EA) classification of boldione, desoxymethyltestos...anabolic steroids", under the Controlled Substance...of the Natural Products Association (NPA), the old...tailers and manufacturers of dietary supplements a...
(Date:12/4/2009)...cans are recruited annually to participate in clin...search Protection (AHRP), and most will be compens...titutions view payments to volunteers as compensat... potential risks related to participating in the e... have a very different view of clinical trial comp...
(Date:12/4/2009)...om federal regulators to crack down on abuse of op...lthDay News) -- The makers of 24 different prescri...lators with plans to curb the abuse of these opioi...een under pressure from U.S. Food and Drug Adminis...ds of fatal overdoses that occur with these medica...
(Date:12/4/2009)...ing drugs known as statins are among the most pres...searchers at Fred Hutchinson Cancer Research Cente...nsplant patients from one of the most serious comp...-versus-host disease, or GVHD. The findings are re... Blood . , In a retrospective study of 567 patien...
(Date:12/4/2009)...ec. 4 When the spread of...artment of Health Services needed to get more info...re. Join Sonic Foundry, Inc. (Nasdaq: SOFO ), t...ing and knowledge management, for a live webinar i...f Health Services, will share how in-house webcast...
Breaking Medicine News(10 mins):Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3[0] Natural Products Association Issues Statement on DEA's Steroid Classification Action[0] Human guinea pigs wary of high-paying medical trials[0] Makers of Powerful Painkillers Present Safety Plans [0] Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD[0] Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |